Drs. Garg and Finger created the first visual acuity prognosis based staging system for retina capillary hemangioma (CRH). It appeared in the May 2020 issue of the Russian Ophthalmological Journal. Their study titled, “Visual Prognosis Based Staging for Retinal Capillary Hemangioma,” was derived from an analysis of the medical literature on Medline and PubMed. Thus, [..] Read More…
Announcing the Essential Eye Cancer Podcast Page with Dr. Paul Finger! Dr. Finger has been working hard to give you this latest addition to the New York Eye Cancer website. For those of you who are auditory learners, these new Podcasts are where you can find your questions answered regarding Dr. Finger’s treatments, techniques and [..] Read More…
Surgical Ophthalmic Oncology: A Collaborative Open Access Reference has been published by Springer Nature and is available for download for free here! Five years ago, The First Eye Cancer Working Day was hosted by The Curie Institute in Paris, France. This was where the idea for the textbook was born, then called a “Collaborative Open [..] Read More…
Watch Dr. Finger’s video here and read along to the transcript provided below! Barton Blackorby: You are the founding member of The New York Eye Cancer Foundation. Could you give some tips on how others can get involved in things like that and how you manage such a busy practice? Paul T. Finger: Back in [..] Read More…
Pakistan is another country claimed by the Eye Cancer Foundation! Recently, Dr. Saima Amin graduated from her training sponsored by the Eye Cancer Foundation in Amman, Jordan at the King Hussain Cancer Center under the training of Dr. Yacoub Yousef. Of the hospital she worked, she notes that unfortunately in order to save their lives, [..] Read More…
Join Dr. Finger and his team at the New York Eye Cancer Center (NYECC)! Currently, there is an opening for a fellowship trained associate specialist to join Dr. Finger in the practice of Ocular Tumor, Orbital Disease, and Ophthalmic Radiation Therapy. The ideal candidate should be able to treat patients with ocular tumors of the [..] Read More…
A recent article was just published in an online magazine called “Southerly” about a possible correlation between cancer incidence in Huntersville, North Carolina and industrial pollution. This relationship was scrutinized upon learning that several high school kids in a school by Lake Norman were diagnosed with ocular cancer. This prompted the residents to look for [..] Read More…
At the 41st Annual Tulane Eye Alumni Day at the Renaissance New Orleans Pere Marquette Hotel, Dr. Finger lectured about how and why his important innovations came to life. In the lecture, he discusses his early work on plaque microwave hyperthermia and TRT for intraocular tumors, pd-103 plaque radiation therapy, the slotted plaque, the amniotic [..] Read More…
New York Magazine recently compiled their annual list of “Best Doctors,” and our very own Dr. Paul Finger is a “Best Doctor” for the 12th time. Castle Connolly Medical Ltd., a New York City research and information company, creates this list yearly by using an online database of more than 53,000 Castle Connolly Top Doctors® [..] Read More…
In 2014, the First Eye Cancer Working Day was hosted by The Curie Institute in Paris, France. There, we decided to develop a Collaborative Open Access Surgical Textbook (COAST) aimed at offering guidance and international outreach for ophthalmologists in countries without eye cancer specialists. The resultant 5-year effort was spearheaded by Drs. Sonal Chaugule, Santosh [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
